NGN-401 — Full data
Late 2026
Initiated PPQ campaign to support BLA submission for NGN-401; completion of PPQ runs expected by end of 2026Source filing
NGNE biotech catalysts & pipeline
NEUROGENE INC · Data as of 2026-09-08
Upcoming catalysts
NGN-401 — Topline data
H2 2027
Completed successful dosing of 25 participants in Embolden; topline data anticipated in the second half of 2027Source filing